Efficacy and tolerability of crizotinib in the treatment of ALK-positive, advanced non-small cell lung cancer in Chinese patients
Crossref DOI link: https://doi.org/10.1007/s12032-015-0626-7
Published Online: 2015-05-13
Published Print: 2015-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Cui, Shaohua
Zhao, Yizhuo
Gu, Aiqin
Ge, Xiaoxiao
Song, Yanyan
Zhang, Wei
Lou, Yuqing
Dong, Lili
Han, Baohui
Jiang, Liyan
Text and Data Mining valid from 2015-05-13